Charles Casamento, Director at Relmada Therapeutics, holds 13.00K shares in Relmada Therapeutics (Ticker: RLMD), holds 2.39K shares in PaxMedica, Inc. (Ticker: PXMD), holds 19.94K shares in Entero Therapeutics (Ticker: ENTO). Most recently, Charles Casamento Bought ― shares of Relmada Therapeutics on Sep 11, 2024 for an estimated value of 33.28K.
Charles Casamento latest transaction was an Informative Buy of $33.28K.
What was Charles Casamento's most profitable transaction?
Charles Casamento’s most profitable transaction was an Informative Sell of ENTO stock on September 18, 2023. The return on the trade was 95.60%.
What is Charles Casamento's role in Relmada Therapeutics?
Charles Casamento's role in Relmada Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.